Patient-Reported Outcomes after Chimeric Antigen Receptor T-Cell (CAR-T) Therapy in Patients with Relapsed/ Refractory Large B-Cell Lymphomas

被引：0
|
作者：
Balitsky, Amaris K. [1 ,2 ]
Pond, Gregory R. [2 ]
Fraser, Graeme [1 ,2 ]
Kouroukis, Tom [1 ,2 ]
Foley, Stephen Ronan [1 ,2 ]
机构：
[1] Hamilton Hlth Sci, Juravinski Canc Ctr, Hamilton, ON, Canada
[2] McMaster Univ, Dept Oncol, Hamilton, ON, Canada
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-165674
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：8036 / 8037
页数：2
相关论文
共 50 条
  • [11] Real-world outcomes of elderly patients with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL) treated with chimeric antigen receptor T-cell (CAR-T) therapy.
    Fitzgerald, Lindsey
    Kittai, Adam
    Nastoupil, Loretta J.
    Waller, Alexandra
    Jacobson, Caron A.
    Saucier, Anna
    Kamdar, Manali K.
    Spradley, Janet
    Denlinger, Nathan
    Chipman, Jonathan
    Hu, Boyu
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [12] Chimeric antigen receptor T-cell therapy for aggressive B-cell lymphomas
    Hu, Bei
    Korsos, Victoria
    Palomba, M. Lia
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [13] Chimeric antigen receptor T-cell treatment patterns in relapsed or refractory large B-cell lymphoma
    Seyedin, Roxanna
    Snider, Julia T.
    Rajagopalan, Krithika
    Wade, Sally W.
    Gergis, Usama
    FUTURE ONCOLOGY, 2023, 19 (22) : 1535 - 1547
  • [14] Second-Line Chimeric Antigen Receptor T Cell Therapy (CAR-T) As Standard of Care for Relapsed-Refractory Large B-Cell Lymphoma (LBCL)
    Dahiya, Saurabh
    Spiegel, Jay Y.
    Lee, Dasom
    Mohammed, Turab
    Lutfi, Forat
    Goyal, Anmol
    Hana, Caroline
    Chavez, Julio C.
    Ionescu, Filip
    Frank, Matthew J.
    Bharadwaj, Sushma
    Sandoval-Sus, Jose
    Beitinjaneh, Amer M.
    Lekakis, Lazaros J.
    McGuirk, Joseph P.
    Locke, Frederick L.
    Miklos, David B.
    Jain, Michael D.
    BLOOD, 2023, 142
  • [15] Outcomes with bridging radiation therapy prior to chimeric antigen receptor T-cell therapy in patients with aggressive large B-cell lymphomas
    Manzar, Gohar S.
    Pinnix, Chelsea C.
    Dudzinski, Stephanie O.
    Marqueen, Kathryn E.
    Cha, Elaine E.
    Nasr, Lewis F.
    Yoder, Alison K.
    Rooney, Michael K.
    Strati, Paolo
    Ahmed, Sairah
    Nze, Chijioke
    Nair, Ranjit
    Fayad, Luis E.
    Wang, Michael
    Nastoupil, Loretta J.
    Westin, Jason R.
    Flowers, Christopher R.
    Neelapu, Sattva S.
    Gunther, Jillian R.
    Dabaja, Bouthaina S.
    Wu, Susan Y.
    Fang, Penny Q.
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [16] Relapsed or refractory large B-cell lymphoma after chimeric antigen receptor T-cell therapy: Current challenges and therapeutic options
    Toro-Mijares, Raul Del
    Oluwole, Olalekan
    Jayani, Reena V.
    Kassim, Adetola A.
    Savani, Bipin N.
    Dholaria, Bhagirathbhai
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 201 (01) : 15 - 24
  • [17] Patient-reported Symptoms Burden after CAR T-cell Therapy for Relapsed/Refractory lymphoma
    Wang, Xin Shelley
    Srour, Samer
    Subbiah, Ishwaria
    Whisenant, Meagan
    Williams, Loretta
    Chen, Tsun Hsuan
    Ponce, Darcy
    Gonzalez, Araceli
    Kamal, Mona
    Ahmed, Sairah
    Kebriaei, Partow
    Neelapu, Sattva
    Shpall, Elizabeth
    QUALITY OF LIFE RESEARCH, 2020, 29 (SUPPL 1) : S77 - S77
  • [18] Impact and safety of chimeric antigen receptor T-cell therapy in older, vulnerable patients with relapsed/refractory large B-cell lymphoma
    Lin, Richard J.
    Lobaugh, Stephanie M.
    Pennisi, Martina
    Chan, Hei Ton
    Batlevi, Yakup
    Ruiz, Josel D.
    Elko, Theresa A.
    Maloy, Molly A.
    Batlevi, Connie L.
    Dahi, Parastoo B.
    Hamlin, Paul A.
    Giralt, Sergio A.
    Hamlin, Paul A.
    Mead, Elena
    Noy, Ariela
    Palomba, M. Lia
    Santomasso, Bianca D.
    Sauter, Craig S.
    Scordo, Michael
    Shah, Gunjan L.
    Korc-Grodzicki, Beatriz
    Kim, Soo Jung
    Silverberg, Mari Lynne
    Brooklyn, Chelsea A.
    Devlin, Sean M.
    Perales, Miguel-Angel
    HAEMATOLOGICA, 2021, 106 (01) : 255 - 258
  • [19] Management of relapsed or refractory large B-cell lymphoma in patients ineligible for CAR-T cell therapy
    Perrone, Salvatore
    Lopedote, Paolo
    Levis, Mario
    Di Rocco, Alice
    Smith, Stephen Douglas
    EXPERT REVIEW OF HEMATOLOGY, 2022, 15 (03) : 215 - 232
  • [20] Treatment outcomes in patients with large B-cell lymphoma after progression to chimeric antigen receptor T-cell therapy
    Iacoboni, Gloria
    Iraola-Truchuelo, Josu
    O'Reilly, Maeve
    Navarro, Victor
    Menne, Tobias
    Kwon, Mi
    Martin-Lopez, Ana africa
    Chaganti, Sridhar
    Delgado, Javier
    Roddie, Claire
    Perez, Ariadna
    Norman, Jane
    Guerreiro, Manuel
    Gibb, Adam
    Caballero, Ana Carolina
    Besley, Caroline
    Martinez-Cibrian, Nuria
    Mussetti, Alberto
    Sanderson, Robin
    Luzardo, Hugo
    Iyengar, Sunil
    Sanchez, Jose Maria
    Jones, Ceri
    Sancho, Juan-Manuel
    Barba, Pere
    Latif, Anne-Louise
    Lopez-Corral, Lucia
    Hernani, Rafael
    Reguera, Juan Luis
    Sureda, Anna
    Garcia-Sancho, Alejandro Martin
    Bastos, Mariana
    Abrisqueta, Pau
    Kuhnl, Andrea
    HEMASPHERE, 2024, 8 (05):
12345